Business Context and Reporting Period
Company: Molina Healthcare, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2004
Reporting Period: The filing addresses events occurring on May 12, 2004, and references financial results for the quarter ended March 31, 2004.
Key Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The filing serves to disclose a material event and references a separate teleconference transcript (Exhibit 99.2) where first-quarter earnings were discussed, but the numerical data is not included in this text.
Material Changes and Events
- Asset Sale Agreement: On May 12, 2004, Molina Healthcare entered into a definitive agreement to transfer the commercial membership of its Cimarron Health Plan to Lovelace Sandia Health System.
- Regulation FD Disclosure: The company held a teleconference on May 12, 2004, to discuss the asset sale and financial results for the quarter ended March 31, 2004.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the asset sale agreement and the subsequent investor communication regarding Q1 2004 results. No specific forward-looking guidance or quantitative outlook is provided within the text of this report.
Risks and Contingencies: The filing notes that the information contained in the teleconference transcript (Exhibit 99.2) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, unless expressly incorporated by specific reference.
Investor Verification Checklist
- Verify the terms and financial impact of the definitive agreement to transfer Cimarron Health Plan's commercial membership to Lovelace Sandia Health System.
- Review Exhibit 99.2 (Transcript of teleconference) for specific Q1 2004 earnings figures and management commentary not present in this summary.
- Confirm the status of the asset sale closing and any regulatory approvals required for the transfer.